TABLE 3.

Factors associated with receiving curative HCC therapies (N = 133).

Characteristic		Univariate analysis		Multivariate analysis
		OR	p	aOR	p
# USs in previous 2 years (odds for each additional US performed)		1.52 (1.14–2.03)	.004	1.53 (1.12–2.09)	.007
Age, per 10‐year increase		0.62 (0.38–0.99)	.047	0.49 (0.28–0.83)	.008
Gender	Female	REF (1.00)	–	REF (1.00)	–
	Male	1.82 (0.74–4.47)	.19	1.40 (0.53–3.72)	.50
Decompensated cirrhosis	No	REF (1.00)	–	REF (1.00)	–
	Yes	0.32 (0.14–0.73)	.007	0.28 (0.11–0.71)	.007

Note: Statistically significant associations are highlighted in grey.